Xilio Therapeutics, Inc. business relationships

Companies named in Xilio Therapeutics, Inc.’s 10-K filed 2026-03-23, and public companies whose annual reports name Xilio Therapeutics, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.

Open on the map Full AI visibility profile

AEO visibility: 4.7 / 10
AI naming: 18 / 100
Agent readiness: 5 / 100
AI adoption: 0 / 100

Named in Xilio Therapeutics, Inc.’s annual report 7

GILEAD SCIENCES, INC. (GILD)Licensor7.7
“Exclusive License Agreement with Gilead” SEC filing
GILEAD SCIENCES, INC. (GILD)Partner7.7
“...ing multiple programs in preclinical and clinical development, including masked multi-specifics, and our clinically-validated masking technology has enabled us to establish top-tier strategic partnerships, including with AbbVie Group Holdings Limited, or AbbVie, and Gilead Sciences, Inc., or Gilead.” SEC filing
Roche GroupPartner7.7
“We record cost-sharing payments under our clinical trial collaboration with Roche as a reduction of research and development costs upon the achievement of each study development event specified in the clinical supply agreement.” SEC filing
Roche GroupSupplier7.7
“Under the clinical supply agreement, the Company is eligible to receive specified cost-sharing payments from Roche, and each company will supply its respective anti-cancer agent to support the Phase 1/2 clinical trial.” SEC filing
AbbVie Inc. (ABBV)Customer5.2
“...everal customer options that were evaluated to determine if such options represented material rights, each of which would be considered a performance obligation at contract inception only if the option provides a material right to AbbVie that it would not receive without entering into that contract.” SEC filing
AbbVie Inc. (ABBV)Licensor5.2
“our ability to maintain our collaboration and license agreements with AbbVie and Gilead;” SEC filing
AbbVie Inc. (ABBV)Partner5.2
“Multi-program collaboration with AbbVie, including a licensed masked antibody program and option to license masked T cell engager program.” SEC filing

Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.